|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 5001 to 5100 out of 5471 for Tyr

0.019s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Protein
Organism: Mus musculus/domesticus
Length: 556  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 841  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 164  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 689  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 564  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 73  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 3262  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 929  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 517  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 100  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 313  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 344  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 108  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 626  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 222  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 973  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 591  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 995  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 432  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 215  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 406  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 417  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 298  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 1052  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 105  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 775  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 354  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 191  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 249  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 1388  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 175  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 206  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 39  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 90  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1275  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 499  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 653  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 355  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 117  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 1430  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1188  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 312  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 321  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 257  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 171  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 87  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 607  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 997  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 55  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 125  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 331  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 458  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 217  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 393  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 286  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 120  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 586  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 1052  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 227  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 58  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 3010  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 688  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 1008  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 115  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1713  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 177  
Fragment?: false
Publication
First Author: Higuchi S
Year: 2007
Journal: Clin Sci (Lond)
Title: Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
Volume: 112
Issue: 8
Pages: 417-28
Publication
First Author: Jakobi R
Year: 1989
Journal: Eur J Biochem
Title: Human phosvitin/casein kinase type II. Molecular cloning and sequencing of full-length cDNA encoding subunit beta.
Volume: 183
Issue: 1
Pages: 227-33
Publication
First Author: Voss H
Year: 1991
Journal: J Biol Chem
Title: Structure of the gene encoding human casein kinase II subunit beta.
Volume: 266
Issue: 21
Pages: 13706-11
Publication
First Author: Reed JC
Year: 1994
Journal: J Biol Chem
Title: Cloning and disruption of CKB2, the gene encoding the 32-kDa regulatory beta'-subunit of Saccharomyces cerevisiae casein kinase II.
Volume: 269
Issue: 27
Pages: 18192-200
Publication
First Author: Bidwai AP
Year: 1995
Journal: J Biol Chem
Title: Cloning and disruption of CKB1, the gene encoding the 38-kDa beta subunit of Saccharomyces cerevisiae casein kinase II (CKII). Deletion of CKII regulatory subunits elicits a salt-sensitive phenotype.
Volume: 270
Issue: 18
Pages: 10395-404
Publication
First Author: Manjasetty BA
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: Crystal structure of a bifunctional aldolase-dehydrogenase: sequestering a reactive and volatile intermediate.
Volume: 100
Issue: 12
Pages: 6992-7
Publication
First Author: Imai Y
Year: 1992
Journal: Mol Cell Biol
Title: Schizosaccharomyces pombe sxa1+ and sxa2+ encode putative proteases involved in the mating response.
Volume: 12
Issue: 4
Pages: 1827-34
Publication
First Author: Sansen S
Year: 2004
Journal: J Biol Chem
Title: Structural basis for inhibition of Aspergillus niger xylanase by triticum aestivum xylanase inhibitor-I.
Volume: 279
Issue: 34
Pages: 36022-8
Publication
First Author: Conway G
Year: 1997
Journal: Proc Natl Acad Sci U S A
Title: Jak1 kinase is required for cell migrations and anterior specification in zebrafish embryos.
Volume: 94
Issue: 7
Pages: 3082-7
Publication
First Author: Lai X
Year: 2009
Journal: Comput Biol Chem
Title: A multi-level model accounting for the effects of JAK2-STAT5 signal modulation in erythropoiesis.
Volume: 33
Issue: 4
Pages: 312-24
Publication
First Author: Chang BY
Year: 2009
Journal: J Immunol
Title: JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL/J mice.
Volume: 183
Issue: 3
Pages: 2183-92
Publication
First Author: Colamonici O
Year: 1994
Journal: Mol Cell Biol
Title: Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
Volume: 14
Issue: 12
Pages: 8133-42
Publication
First Author: Wilks AF
Year: 1991
Journal: Mol Cell Biol
Title: Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.
Volume: 11
Issue: 4
Pages: 2057-65
Publication
First Author: Usacheva A
Year: 2002
Journal: J Immunol
Title: Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors.
Volume: 169
Issue: 3
Pages: 1302-8
Publication
First Author: Gruber CN
Year: 2020
Journal: Immunity
Title: Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function.
Volume: 53
Issue: 3
Pages: 672-684.e11
Publication
First Author: Staerk J
Year: 2005
Journal: J Biol Chem
Title: JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor.
Volume: 280
Issue: 51
Pages: 41893-9
Protein Domain
Type: Family
Description: Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []:Serine/threonine-protein kinasesTyrosine-protein kinasesDual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins)Protein kinase function is evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases [].Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []:Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases [].Janus kinases (JAKs) are tyrosine kinases that function in membrane-proximal signalling events initiated by a variety of extracellular factors binding to cell surface receptors []. Many type I and II cytokine receptors lack a protein tyrosine kinase domain and rely on JAKs to initiate the cytoplasmic signal transduction cascade. Ligand binding induces oligomerisation of the receptors, which then activates the cytoplasmic receptor-associated JAKs. These subsequently phosphorylate tyrosine residues along the receptor chains with which they are associated. The phosphotyrosine residues are a target for a variety of SH2 domain-containing transducer proteins. Amongst these are the signal transducers and activators of transcription (STAT) proteins, which, after binding to the receptor chains, are phosphorylated by the JAK proteins. Phosphorylation enables the STAT proteins to dimerise and translocate into the nucleus, where they alter the expression of cytokine-regulated genes. This system is known as the JAK-STAT pathway.Four mammalian JAK family members have been identified: JAK1, JAK2, JAK3, and TYK2. They are relatively large kinases of approximately 1150 amino acids, with molecular weights of ~120-130kDa. Their amino acid sequences are characterised by the presence of 7 highly conserved domains, termed JAK homology (JH) domains. The C-terminal domain (JH1) is responsible for the tyrosine kinase function. The next domain in the sequence (JH2) is known as the tyrosine kinase-like domain, as its sequence shows high similarity to functional kinases but does not possess any catalytic activity. Although the function of this domain is not well established, there is some evidence for a regulatory role on the JH1 domain, thus modulating catalytic activity. The N-terminal portion of the JAKs (spanning JH7 to JH3) is important for receptor association and non-catalytic activity, and consists of JH3-JH4, which is homologous to the SH2 domain, and lastly JH5-JH7, which is a FERM domain.This entry represents the non-receptor tyrosine kinases Jak and Tyk2:Jak1 appears to be required in early development for specific cell migrations (epiboly), for the expression of the homeobox protein goosecoid and for the formation of anterior structures [].Jak2 plays a role in leptin signalling and in the control of body weight. It is involved in interleukin-3, and probably interleukin-23, signal transduction [].Jak3 is involved in the interleukin-2 and interleukin-4 signalling pathway. It phosphorylates STAT6, IRS1, IRS2 and PI3K [].Tyk2 is probably involved in intracellular signal transduction by being involved in the initiation of type I IFN signalling. It phosphorylates the interferon-alpha/beta receptor alpha chain [].
Protein Domain
Type: Family
Description: Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []:Serine/threonine-protein kinasesTyrosine-protein kinasesDual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins)Protein kinase function is evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases [].Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []:Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases [].Janus kinases (JAKs) are tyrosine kinases that function in membrane-proximal signalling events initiated by a variety of extracellular factors binding to cell surface receptors []. Many type I and II cytokine receptors lack a protein tyrosine kinase domain and rely on JAKs to initiate the cytoplasmic signal transduction cascade. Ligand binding induces oligomerisation of the receptors, which then activates the cytoplasmic receptor-associated JAKs. These subsequently phosphorylate tyrosine residues along the receptor chains with which they are associated. The phosphotyrosine residues are a target for a variety of SH2 domain-containing transducer proteins. Amongst these are the signal transducers and activators of transcription (STAT) proteins, which, after binding to the receptor chains, are phosphorylated by the JAK proteins. Phosphorylation enables the STAT proteins to dimerise and translocate into the nucleus, where they alter the expression of cytokine-regulated genes. This system is known as the JAK-STAT pathway.Four mammalian JAK family members have been identified: JAK1, JAK2, JAK3, and TYK2. They are relatively large kinases of approximately 1150 amino acids, with molecular weights of ~120-130kDa. Their amino acid sequences are characterised by the presence of 7 highly conserved domains, termed JAK homology (JH) domains. The C-terminal domain (JH1) is responsible for the tyrosine kinase function. The next domain in the sequence (JH2) is known as the tyrosine kinase-like domain, as its sequence shows high similarity to functional kinases but does not possess any catalytic activity. Although the function of this domain is not well established, there is some evidence for a regulatory role on the JH1 domain, thus modulating catalytic activity. The N-terminal portion of the JAKs (spanning JH7 to JH3) is important for receptor association and non-catalytic activity, and consists of JH3-JH4, which is homologous to the SH2 domain, and lastly JH5-JH7, which is a FERM domain.This represents the non-receptor tyrosine kinase JAK1, which is involved in the IFN-alpha/beta/gamma signal pathway. Jak1 acts as the kinase partner for the interleukin (IL)-2 receptor []and interleukin (IL)-10 receptor []. It directly phosphorylates STAT but also activates STAT signalling through the transactivation of other JAK kinases associated with signalling receptors [, ].JAK1 was initially cloned using a PCR-based strategy utilising degenerateprimers corresponding to conserved motifs within the catalytic domain of protein-tyrosine kinases []. In common with JAK2 and TYK2, and by contrastwith JAK3, JAK1 appears to be ubiquitously expressed.
Protein
Organism: Mus musculus/domesticus
Length: 1153  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1126  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1153  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1153  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1009  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1052  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1093  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 967  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1009  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1068  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 967  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1005  
Fragment?: false
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Mouse Synonym Curation
Protein
Organism: Mus musculus/domesticus
Length: 223  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1998  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1238  
Fragment?: false